CTRI/2019/04/018699已完成2 期
To Study the Effects of Extended Doses of Lipid Emulsion in Organophosphate Compound Poisoning: Randomised Controlled Trial
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- PGIMER
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.History of consumption of organophosphate compound.
- •2.Clinical manifestations of moderate or severe organophosphorus compound poisoning as per Peradeniya Severity Score.
- •3.Informed consent from the patient or next kin.
排除标准
- •1.Where the compound ingested could not be identified.
- •2.History of combined poisoning with a non-OP compound.
- •3.All other patients not fitting in the organophosphate symptom complex.
- •4.Patients having underlying kidney and liver ailments.
- •5.History suggestive of acute pancreatitis in the past.
研究者
相似试验
已完成
不适用
Clinical study to investigate lipid-modifying effects of a Saskatoon berry extract - a randomized, double-blind, placebo-controlled parallel studyHealthy subjectsDRKS00015503Prairie Berries Europe GmbH50
已完成
不适用
Clinical study to investigate lipid modifying effects of hydroxytyrosol – a randomized, double-blind, placebo-controlled parallel studyHealthy subjects with slight to moderately elevated LDL-cholesterol level.DRKS00015251Wacker Chemie AG92
已完成
不适用
The effecs of intensive lipid-lowering therapy on the progression of atherosclerotic kidney diseasechronic kidney diseaseJPRN-UMIN000021356niversity, School of Medicine40
已完成
不适用
Clinical trials of the lipid improvement effect of Goishi tea evaluated by index LDL cholesterolHealthy individualJPRN-UMIN000024028Kochi medical school hospital80
招募中
不适用
Prospective investigation of clinical, lipidological, vascular and hepatic parameters with regard to cardiovascular risk factors and primary prevention in childhoodDRKS00031182Goethe Universität, Klinikum300